Massive parallel sequencing determined that some CTCL samples exhibited PLCG1 mutations, which was linked with increased NFAT activation that appeared to drive CTCL proliferation and cell survival (54). This evidence concerns the gene PLCG1 and primary cutaneous T-cell non-Hodgkin lymphoma.